Stacey Rifkin-Zenenberg

Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C

Hilary Whitworth, Sarah E. Sartain, Riten Kumar et al. · Blood · 2021 · 214 citations · Full text

Medicine, Infectious Diseases, Pediatrics +10

Initial Results from the BEACON Clinical Study: A Phase 1/2 Study Evaluating the Safety and Efficacy of a Single Dose of Autologous CD34+ Base Edited Hematopoietic Stem Cells (BEAM-101) in Patients with Sickle Cell Disease with Severe Vaso-Occlusive Crises

Ashish O. Gupta, Akshay Sharma, Haydar Frangoul et al. · Blood · 2024 · 16 citations

Life Sciences, Biotechnology, Hematology +16

Resolution of Serious Vaso-Occlusive Pain Crises and Reduction in Patient-Reported Pain Intensity: Results from the Ongoing Phase 1/2 HGB-206 Group C Study of LentiGlobin for Sickle Cell Disease (bb1111) Gene Therapy

Alexis A. Thompson, Mark C. Walters, Markus Y. Mapara et al. · Blood · 2020 · 15 citations

Medicine, Hematology, Gene Therapy +14

Efficacy, Safety, and Health-Related Quality of Life (HRQOL) in Patients with Sickle Cell Disease (SCD) Who Have Received Lovotibeglogene Autotemcel (Lovo-cel) Gene Therapy: Up to 60 Months of Follow-up

Julie Kanter, Alexis A. Thompson, Janet L. Kwiatkowski et al. · Blood · 2023 · 15 citations

Medicine, Hematology, Translational Sciences +14

An Update on Lovotibeglogene Autotemcel (Lovo-cel) Clinical Trials for Sickle Cell Disease (SCD) and Analysis of Early Predictors of Response to Lovo-Cel

Stacey Rifkin-Zenenberg, Julie Kanter, Melissa A. Kinney et al. · Blood · 2024 · 12 citations · Full text

Medicine, Hematology, Pharmacotherapy +13